THC Farmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Jun '15 Jun 30, 2015	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012	Sep '11 Sep 30, 2011	Sep '10 Sep 30, 2010
Net Income	-0.07	-0.03	-0.02	-0.04	-0.03	-0.01
Depreciation & Amortization	0	0	0	0	0.01	0
Loss (Gain) From Sale of Assets	-	-	-	0	-	0
Asset Writedown & Restructuring Costs	-	-	-	0.01	-	0.01
Other Operating Activities	-0.03	-	-	-	-	0.01
Change in Accounts Receivable	-0	-0	0	0	0	-0
Change in Accounts Payable	0.01	0	-0	-0	0	-0
Change in Other Net Operating Assets	-1.43	0.01	0	0	0.04	-
Operating Cash Flow	-1.51	-0.02	-0.02	-0.02	0.02	0
Operating Cash Flow Growth	-	-	-	-	574.68%	-45.63%
Sale of Property, Plant & Equipment	-	-	-	0	-	-
Other Investing Activities	-	-	-	-	-	-0.01
Investing Cash Flow	-0.01	-	-	0	-	-0.01
Long-Term Debt Issued	-	0.02	0.02	0.02	0.02	-
Long-Term Debt Repaid	-	-0	-0	-0	-0.04	-
Net Debt Issued (Repaid)	0.61	0.02	0.02	0.02	-0.02	-
Issuance of Common Stock	1.13	-	-	-	-	-
Financing Cash Flow	1.52	0.02	0.02	0.02	-0.02	-
Net Cash Flow	0	0	-0	-0	-0	-0
Free Cash Flow	-1.51	-0.02	-0.02	-0.02	0.02	0
Free Cash Flow Growth	-	-	-	-	574.68%	-2.37%
Free Cash Flow Margin	-8146.50%	-99.31%	-88.78%	-72.69%	60.22%	7.99%
Free Cash Flow Per Share	-0.11	-0.00	-0.00	-0.00	0.00	0.00
Cash Interest Paid	-	0	0	0	0.01	0
Cash Income Tax Paid	0	0	0	-	-	-
Levered Free Cash Flow	-0.04	-0.01	-0.01	-0.01	-0.01	-
Unlevered Free Cash Flow	-0.04	-0.01	-0.01	-0.01	-0.01	-
Change in Working Capital	-1.41	0.01	0	0	0.04	-0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.